title: Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
abstract: The cell membrane antigens epithelial membrane antigen (EMA), epithelial glycoprotein 34, (egp34), BW-495 and tumor-associated antigen 72 (TAG-72) are present in most benign and malignant epithelial cells and can be demonstrated with the help of monoclonal antibodies. In a study on the identification of carcinoma cells in samples of ascitic and pleural fluid involving 170 patients, we compared the value of immunocytochemical labeling of these antigens with that of immunocytochemical demonstration of carcinoembryonic antigen (CEA). Antibodies to EMA and egp34 occasionally also reacted with reactively proliferating mesothelial cells in benign conditions and thus appear to be inappropriate for diagnostic use. Cells positive for BW-495, TAG-72 and CEA, however, have never been found in benign conditions; the specificity of these antigens thus permits their use in diagnosis. Antigen-expressing cells were found in 85% (BW-495), 62% (TAG-72) and 60% (CEA) of cytologically positive samples from carcinoma patients. Similarly, positive reactions for BW-495, TAG-72 and CEA were observed in, respectively, 36%, 29% and 34% of cytologically negative or suspicious samples. BW-495 thus appears to be a suitable marker for the demonstration of carcinoma cells in samples of pleural and ascitic fluid and to have a higher degree of sensitivity than does either TAG-72 or CEA.
authors.affiliation: Department of Internal Medicine III, Klinikum, Grosshadern, University of Munich, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Mezger
authors.forename: O
authors.initials: O
authors.lastname: Stötzer
authors.forename: G
authors.initials: G
authors.lastname: Schilli
authors.forename: S
authors.initials: S
authors.lastname: Bauer
authors.forename: W
authors.initials: W
authors.lastname: Wilmanns
mesh_terms: D000951:Antigens, Neoplasm / Q000032:analysis*; D001202:Ascitic Fluid / Q000276:immunology* / Q000473:pathology; D014408:Biomarkers, Tumor / Q000276:immunology*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D008562:Membrane Glycoproteins / Q000032:analysis; D018396:Mucin-1; D009369:Neoplasms / Q000276:immunology* / Q000473:pathology; D010996:Pleural Effusion / Q000276:immunology* / Q000473:pathology; D016066:Pleural Effusion, Malignant / Q000276:immunology / Q000473:pathology
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D018396:Mucin-1; C047052:tumor-associated antigen 72